Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Ip Group Share News (IPO)
IPO Share
Price
IPO Share
News
IPO Share
Chat
IPO Share
Trades180
IPO
Live RNS
IPO Share
Charts
IPO Level 2
Console
IPO Live
Share Price
IPO Broker
Ratings
IPO Directors
Deals
IPO Financial
Diary
IPO
Fundamentals
IPO Short
Positions
IPO
Media
IPO Company
Research
IPO Company
Timeline
Share Price Information for Ip Group (IPO)
Last checked at -
Last checked at 
Intraday Ip Group Share Chart
IP Group Chairman Bruce Smith To Step Down
LONDON (Alliance News) - IP Group PLC on Wednesday said its chairman is to step down, but will stay in the position until a successor is appointed.
Bruce Smith joined the board of the FTSE 250 intellectual property company in September 2002 and has served as non-executive chairman since it floated on the stock market in 2003.
"Bruce has made an outstanding contribution to the Company over the last twelve years. On behalf of the Board and all of the Company's staff, I would like to thank Bruce for his wise counsel over the years and to wish him well in his retirement," said IP Group Chief Executive Alan Aubrey.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Latest IPO News
- IP Group investee Istesso starts phase 2 arthritis trial of leramistat
16 Jun 2026 - IP Group portfolio company begins dosing patients in Phase 2 trial
16 Jun 2026 - UK shareholder meetings calendar - next 7 days
11 Jun 2026 - WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
3 Jun 2026 - IP Group cheers trial results for Enterprise drug candidate
12 May 2026 - IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint
7 May 2026 - LONDON BROKER RATINGS: Jefferies cuts National Grid to 'hold'
18 Mar 2026 - IP Group asset value grows, remains confident in biotech potential
17 Mar 2026
Related News
IP Group investee Istesso starts phase 2 arthritis trial of leramistat
(Alliance News) - IP Group PLC on Tuesday announced that portfolio company Istesso has commenced dosing for the IST-03 trial of leramistat in sarcopen...
IP Group portfolio company begins dosing patients in Phase 2 trial
(Sharecast News) - Science and technology investment firm IP Group said on Tuesday that portfolio company Istesso has begun dosing patients in a Phase...
Ip Group News
IP Group investee Istesso starts phase 2 arthritis trial of leramistat
(Alliance News) - IP Group PLC on Tuesday announced that portfolio company Istesso has commenced dosing for the IST-03 trial of leramistat in sarcopen...
IP Group portfolio company begins dosing patients in Phase 2 trial
(Sharecast News) - Science and technology investment firm IP Group said on Tuesday that portfolio company Istesso has begun dosing patients in a Phase...
WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.
IP Group cheers trial results for Enterprise drug candidate
(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms.
IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint
IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executi...
LONDON BROKER RATINGS: Jefferies cuts National Grid to 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
IP Group asset value grows, remains confident in biotech potential
(Alliance News) - IP Group PLC on Tuesday highlighted a successful acquisition by portfolio holding Pfizer Inc, as the investor in science and technol...
Follow the stocks
